Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Non-resectable”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03201458
What this trial is testing

Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

Who this might be right for
Gallbladder CarcinomaMetastatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more
National Cancer Institute (NCI) 86
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableStudy completedNCT05028439
What this trial is testing

RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First People's Hospital of Hangzhou 70
Testing effectiveness (Phase 2)UnknownNCT05738057
What this trial is testing

Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Hua Li 22
Not applicableStudy completedNCT01844245
What this trial is testing

Endobiliary RFA for Unresectable Malignant Biliary Strictures

Who this might be right for
CholangiocarcinomaAmpullary Carcinoma
Bing Hu 174
Testing effectiveness (Phase 2)UnknownNCT05400902
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Binkui Li 17
Large-scale testing (Phase 3)WithdrawnNCT00253617
What this trial is testing

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctCholangiocarcinoma of the GallbladderUnresectable Extrahepatic Bile Duct Cancer+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Enrolling By InvitationNCT06671418
What this trial is testing

Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

Who this might be right for
Cholangiocarcinoma Non-resectableGall Bladder CancerLiver Metastasis+1 more
Erasmus Medical Center 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT07765433
What this trial is testing

Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract AdenocarcinomaLocally Advanced Extrahepatic CholangiocarcinomaLocally Advanced Intrahepatic Cholangiocarcinoma+12 more
ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Study completedNCT01242605
What this trial is testing

ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaGallbladder Neoplasms
University College, London 13
Not applicableEnded earlyNCT02256982
What this trial is testing

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic CholangiocarcinomaResectable Intrahepatic Cholangiocarcinoma
Massachusetts General Hospital 3
Testing effectiveness (Phase 2)UnknownNCT05991518
What this trial is testing

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

Who this might be right for
HER2 Gene Mutation
SUNHO（China）BioPharmaceutical CO., Ltd. 136
Testing effectiveness (Phase 2)UnknownNCT04413734
What this trial is testing

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma by AJCC V8 Stage
Zhejiang University 120
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT02955771
What this trial is testing

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Who this might be right for
Hilar Cholangiocarcinoma
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 7
Next Page
336